Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Tango Therapeutics (TNGX) Net Income towards Common Stockholders: 2020-2024

Historic Net Income towards Common Stockholders for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to -$130.3 million.

  • Tango Therapeutics' Net Income towards Common Stockholders rose 154.46% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.5 million, marking a year-over-year increase of 18.57%. This contributed to the annual value of -$130.3 million for FY2024, which is 28.07% down from last year.
  • As of FY2024, Tango Therapeutics' Net Income towards Common Stockholders stood at -$130.3 million, which was down 28.07% from -$101.7 million recorded in FY2023.
  • Tango Therapeutics' Net Income towards Common Stockholders' 5-year high stood at -$52.0 million during FY2020, with a 5-year trough of -$130.3 million in FY2024.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was -$108.2 million (2022), whereas its average is -$113.4 million.
  • As far as peak fluctuations go, Tango Therapeutics' Net Income towards Common Stockholders tumbled by 85.81% in 2022, and later increased by 5.99% in 2023.
  • Over the past 5 years, Tango Therapeutics' Net Income towards Common Stockholders (Yearly) stood at -$52.0 million in 2020, then decreased by 12.07% to -$58.2 million in 2021, then plummeted by 85.81% to -$108.2 million in 2022, then rose by 5.99% to -$101.7 million in 2023, then dropped by 28.07% to -$130.3 million in 2024.